...
首页> 外文期刊>Nutrition & Diabetes >Geographical variation in the prevalence of obesity, metabolic syndrome, and diabetes among US adults
【24h】

Geographical variation in the prevalence of obesity, metabolic syndrome, and diabetes among US adults

机译:美国成年人中肥胖,代谢综合征和糖尿病患病率的地理差异

获取原文

摘要

Cardiovascular disease (CVD) and type 2 diabetes remain significant public health concerns. Targeting of prevention efforts by geographical location has been suggested by the Institute of Medicine to coincide with the presence of area-based risk. The metabolic syndrome (MetS) is a stronger risk factor than is obesity for the prediction of future CVD and diabetes, yet its prevalence has not previously been described geographically. Our objective is to determine geographical variation in the prevalence of obesity, MetS, and diabetes among US adults. We assessed the prevalence of obesity, MetS, and diabetes by US census division, and the prevalence of obesity, MetS, and diabetes for each sex and racial/ethnic group by US region among 9826 US non-Hispanic white, non-Hispanic black, and Hispanic adults aged 20–65 years participating in the National Health and Nutrition Examination Survey 1999–2014. We also compared a sex- and race/ethnicity-specific MetS severity score by geographical area. The prevalence of obesity, MetS, and diabetes varied by US census division and region, with overall similarity by geographical area in the prevalence of each of these conditions. The prevalence of MetS was particularly high (≥35%) in the West North Central, West South Central, and East South Central and low (30%) in the Pacific, New England, and Mid-Atlantic divisions. Some of the geographical variation appeared due to differences among non-Hispanic white females, who had a high prevalence of MetS (>32%) in the Midwest and South and a low prevalence of MetS (24%) in the West and Northeast. Geographical differences in MetS imply variation in the risk for future CVD and diabetes, with more elevated risk in the center of the United States. As MetS is a stronger risk factor for prediction of CVD and T2DM than is obesity, these differences are potentially important for prompting public health efforts toward surveillance and prevention in high-risk areas.
机译:心血管疾病(CVD)和2型糖尿病仍然是重要的公共健康问题。医学研究所已建议按地理位置确定预防工作的目标,以与存在基于区域的风险相吻合。代谢综合症(MetS)是比肥胖症更强的危险因素,可以用来预测将来的CVD和糖尿病,但以前尚未在地理上描述其流行程度。我们的目标是确定美国成年人中肥胖,MetS和糖尿病患病率的地理差异。我们根据美国人口普查部门评估了肥胖,MetS和糖尿病的患病率,并评估了9826个美国非西班牙裔白色,非西班牙裔黑人,美国,美国和美国各性别和种族/族裔的肥胖,MetS和糖尿病的患病率,以及20岁至65岁的西班牙裔成年人参加了1999年至2014年国家健康和营养调查。我们还按地区比较了性别和种族/族裔特定的MetS严重程度得分。肥胖,MetS和糖尿病的患病率随美国人口普查部门和地区的不同而有所差异,而每种疾病的患病率在总体地理区域上都相似。在西北中部,西南中部和东南中部,MetS的患病率特别高(≥35%),在太平洋,新英格兰和中大西洋地区的MetS患病率特别低(30%)。某些地理差异是由于非西班牙裔白人女性之间的差异而引起的,这些女性在中西部和南部的MetS患病率较高(> 32%),而在西部和东北部的MetS患病率较低(24%)。 MetS的地域差异意味着未来CVD和糖尿病的风险有所不同,在美国中部,风险更高。与肥胖相比,MetS是预测CVD和T2DM的更强风险因素,因此这些差异对于促使公共卫生朝着高风险地区的监测和预防工作具有潜在的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号